emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

Zeria Pharmaceutical Co / Tillotts Pharma

No EMAT : 20284
Announced Date : 04/08/2009
Type : Acquisition of Majority Stake
Deal Value : Yes
Acquirer : Zeria Pharmaceutical Co

Target : Tillotts Pharma
Country : Switzerland
Sector of activity :
  • Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Founded in 1986, Tillotts Pharma AG develops, produces, and markets branded pharmaceutical products for the treatment of gastroenterology diseases . The company specializes in the therapy of the...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic
Current
Rating : *
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
16/06/2008 Essilor International Satisloh Holding Switzerland ** 20253
13/02/2008 Hygeia SA - Diagnostic & Medical Center of Athens Maternity & Gynecological Clinic Evangelismos Cyprus * 20241

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report